- Home
- UGI vs BIO Comparison
UGI vs BIO Comparison
Compare UGI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGI
- BIO
- Stock Information
- Founded
- UGI 1940
- BIO 1952
- Country
- UGI United States
- BIO United States
- Employees
- UGI N/A
- BIO N/A
- Industry
- UGI Natural Gas Distribution
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- UGI Utilities
- BIO Industrials
- Exchange
- UGI Nasdaq
- BIO Nasdaq
- Market Cap
- UGI 6.9B
- BIO 6.9B
- IPO Year
- UGI N/A
- BIO N/A
- Fundamental
- Price
- UGI $32.76
- BIO $249.21
- Analyst Decision
- UGI Buy
- BIO Strong Buy
- Analyst Count
- UGI 2
- BIO 4
- Target Price
- UGI $27.50
- BIO $396.50
- AVG Volume (30 Days)
- UGI 2.4M
- BIO 385.0K
- Earning Date
- UGI 05-07-2025
- BIO 05-01-2025
- Dividend Yield
- UGI 4.62%
- BIO N/A
- EPS Growth
- UGI N/A
- BIO N/A
- EPS
- UGI 2.55
- BIO N/A
- Revenue
- UGI $7,119,000,000.00
- BIO $2,566,500,000.00
- Revenue This Year
- UGI $6.27
- BIO $0.88
- Revenue Next Year
- UGI $8.25
- BIO $4.44
- P/E Ratio
- UGI $12.72
- BIO N/A
- Revenue Growth
- UGI N/A
- BIO N/A
- 52 Week Low
- UGI $22.01
- BIO $215.38
- 52 Week High
- UGI $34.49
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- UGI 53.67
- BIO 51.05
- Support Level
- UGI $31.90
- BIO $232.53
- Resistance Level
- UGI $33.50
- BIO $252.41
- Average True Range (ATR)
- UGI 1.13
- BIO 12.23
- MACD
- UGI 0.13
- BIO 2.59
- Stochastic Oscillator
- UGI 82.52
- BIO 75.82
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.